THOMAS FEENY: Open Payments
NPI 1467478024 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,086 in 209 payments from 21 companies in 2025. Trend: 2023 $583 · 2024 $2,637 · 2025 $4,086
Food & beverage: $3,998Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $1,136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 54 | $683 |
| Janssen Biotech, Inc. | 15 | $366 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $331 |
| GENZYME CORPORATION | 12 | $226 |
| Lilly USA, LLC | 9 | $178 |
| Novo Nordisk Inc | 4 | $167 |
| EVOKE PHARMA, INC. | 4 | $161 |
| QOL Medical, LLC | 5 | $131 |
| Braintree Laboratories, Inc. | 3 | $107 |
Products named: XIFAXAN, RINVOQ, TREMFYA, SKYRIZI, CREON, ENTYVIO, DUPIXENT, OMVOH.
Industry payments across OH — which companies pay providers there.
